Geiculescu I.Niklinska-Schirtz B.J.Munasinghe S.Rajendra C.Poddar U.Tanpowpong P.Escher J.C.Rajindrajith S.Day A.S.Kugathasan S.Mahidol University2026-05-112026-05-112026-05-01Inflammatory Bowel Diseases Vol.32 No.5 (2026) , 998-100410780998https://repository.li.mahidol.ac.th/handle/123456789/116655Access to quality healthcare for individuals with chronic diseases like inflammatory bowel disease (IBD) remains a global challenge. Tweens (aged 9-12 years) and teens (typically aged 13-19 years) with IBD face unique challenges compared to adults, including limited access to medications, difficulties transitioning to adult care, and barriers to clinical trial enrollment. Additional concerns include mental health, social media influence, and growth through puberty. This review article brings together current evidence reported by pediatric IBD clinicians worldwide to highlight these issues. While many challenges are universal, some are region specific and reflect geographic disparities in care.MedicineReviewSCOPUS10.1093/ibd/izag0102-s2.0-1050378377361536484441762694